BALPHARMA

Bal Pharma Share Price Bal Pharma

₹91.2
-3.95 (-4.15%)
29 March, 2024 00:07 BSE: 524824 NSE: BALPHARMAISIN: INE083D01012

Start SIP in Bal Pharma

Start SIP

Bal Pharma Performance

Day Range

  • Low 90
  • High 97
₹ 91

52 Week Range

  • Low 63
  • High 132
₹ 91
  • Open Price95
  • Previous Close95
  • Volume46752

Bal Pharma Share Price

  • Over 1 Month -17.69%
  • Over 3 Month -9.21%
  • Over 6 Month -2.77%
  • Over 1 Year 39.66%

Bal Pharma Key Statistics

P/E Ratio 41
PEG Ratio 3.7
Market Cap Cr 144
Price to Book Ratio 2.3
EPS 3.9
Dividend 1.1
Relative Strength Index 32.81
Money Flow Index 46.81
MACD Signal -4.94
Average True Range 5.51
Bal Pharma Financials
IndicatorDec 2023Sep 2023Jun 2023Mar 2023
Oper Rev Qtr Cr 81927082
Operating Expenses Qtr Cr 74856374
Operating Profit Qtr Cr 8878
Depreciation Qtr Cr 3222
Interest Qtr Cr 4444
Tax Qtr Cr 0101
Net Profit Qtr Cr 1212
IndicatorMar 2023
Total Revenue Annual Cr 305
Operating Expenses Annual Cr 277
Operating Profit Annual in Cr 26
Depreciation Cr 7
Interest Annual Cr 12
Tax Annual Cr 2
Net Profit Annual Cr 6
IndicatorMar 2023
Cash from Operating Activity Annual Cr 5
Cash from Investing Activity Annual Cr -22
Cash from Financing Annual Activity Cr 17
Net Cash Flow Annual Cr 0
IndicatorMar 2023
Total ShareHolders Funds Annual Cr 96
Fixed Assets Annual Cr 63
Total Non Current Assets Annual Cr 78
Total Current Assets Annual Cr 270
Total Assets Annual Cr 348
IndicatorMar 2023
Book Value Per Share Annual Rs 61
ROE Annual % 6
ROCE Annual % 15
Total Debt to Total Equity Annual -
EBDIT Annual Margin % 9
IndicatorDec 2023Sep 2023Jun 2023Mar 2023
Oper Rev Qtr Cr 82937082
Operating Expenses Qtr Cr 74856474
Operating Profit Qtr Cr 8868
Depreciation Qtr Cr 3232
Interest Qtr Cr 4444
Tax Qtr Cr 0101
Net Profit Qtr Cr 1102
IndicatorMar 2023
Total Revenue Annual Cr 305
Operating Expenses Annual Cr 279
Operating Profit Annual in Cr 25
Depreciation Cr 9
Interest Annual Cr 12
Tax Annual Cr 2
Net Profit Annual Cr 3
IndicatorMar 2023
Cash from Operating Activity Annual Cr -2
Cash from Investing Activity Annual Cr -22
Cash from Financing Annual Activity Cr 24
Net Cash Flow Annual Cr 0
IndicatorMar 2023
Total ShareHolders Funds Annual Cr 64
Fixed Assets Annual Cr 73
Total Non Current Assets Annual Cr 85
Total Current Assets Annual Cr 228
Total Assets Annual Cr 313
IndicatorMar 2023
Book Value Per Share Annual Rs 41
ROE Annual % 4
ROCE Annual % 16
Total Debt to Total Equity Annual -
EBDIT Annual Margin % 9

Bal Pharma Technicals

EMA & SMA

Current Price
₹91.2
-3.95 (-4.15%)
pointer
  • Bullish Moving Average
  • ___
  • 0
  • Bearish Moving Average
  • ___
  • 16
  • 20 Day
  • ₹100.70
  • 50 Day
  • ₹106.35
  • 100 Day
  • ₹106.03
  • 200 Day
  • ₹101.88
  • 20 Day
  • ₹101.23
  • 50 Day
  • ₹111.70
  • 100 Day
  • ₹108.32
  • 200 Day
  • ₹100.85

Bal Pharma Resistance and Support

PIVOT
₹92.62
Resistance
First Resistance 95.13
Second Resistance 99.07
Third Resistance 101.58
RSI 32.81
MFI 46.81
MACD Single Line -4.94
MACD -5.12
Support
First Resistance 88.68
Second Resistance 86.17
Third Resistance 82.23

Bal Pharma Delivery and Volume

Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
Day 58,153 3,679,922 63.28
Week 33,857 2,223,067 65.66
1 Month 27,305 1,826,724 66.9
6 Month 81,788 4,420,633 54.05

Bal Pharma Result Highlights

Bal Pharma Synopsis

NSE-Medical-Diversified

Bal Pharma Ltd belongs to the Industry of Pharmaceuticals. Company’s Total Operating Revenue is Rs. 303.10 Cr. and Equity Capital is Rs. 15.69 Cr. for the Year ended 31/03/2023. Bal Pharma Ltd. is a Public Limited Listed company incorporated on 19/05/1987 and has its registered office in the State of Karnataka, India. Company’s Corporate Identification Number(CIN) is L85110KA1987PLC008368 and registration number is 008368.
Market Cap 144
Sales 326
Shares in Float 0.77
No of funds 1
Yield 1.05
Book Value 1.49
U/D Vol ratio 1.3
LTDebt / Equity 32
Alpha -0.01
Beta 1.46

Bal Pharma

Owner NameDec-23Sep-23Jun-23Mar-23
Promoters 51.23%51.61%51.61%51.61%
Foreign Portfolio Investors 0.13%0.14%0.17%0.17%
Individual Investors 32.64%32.19%31.99%32.07%
Others 16%16.06%16.23%16.15%

Bal Pharma Management

Name Designation
Mr. Shailesh D Siroya Managing Director
Mr. Himesh Virupakshaya Executive Director
Mr. Jatish Sheth Independent Director
Dr. C V Srinivas Independent Director
Ms. Nicloa Neeladri Independent Director
Mr. H S Venkatesh Independent Director
Mr. Kotian Chittananda Damodar Executive Director

Bal Pharma Forecast

Price Estimates

2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)

Other Analyst Rating

Bal Pharma Corporate Action

Date Purpose Remarks
2024-02-12 Quarterly Results
2023-11-08 Quarterly Results & ESOP
2023-08-11 Quarterly Results & A.G.M.
2023-05-29 Audited Results & Final Dividend
2023-02-06 Quarterly Results

Bal Pharma MF Shareholding

Name Amount(cr)

Bal Pharma FAQs

What is Share Price of Bal Pharma ?

Bal Pharma share price is ₹91 As on 28 March, 2024 | 23:53

What is the Market Cap of Bal Pharma ?

The Market Cap of Bal Pharma is ₹144.1 Cr As on 28 March, 2024 | 23:53

What is the P/E ratio of Bal Pharma ?

The P/E ratio of Bal Pharma is 41 As on 28 March, 2024 | 23:53

What is the PB ratio of Bal Pharma ?

The PB ratio of Bal Pharma is 2.3 As on 28 March, 2024 | 23:53

Q2FY23